Common use
Capnat is an oral chemotherapy medication containing capecitabine, the same clinically proven active ingredient found in the well-established brand Xeloda. When you buy Capnat online, you receive a high-quality, rigorously tested Xeloda generic belonging to the fluoropyrimidine class of antimetabolite drugs — one of the most important categories of cancer treatment agents in modern oncology. Capecitabine is an ingeniously designed oral prodrug that undergoes a three-step enzymatic conversion process in the body, ultimately being converted to the potent anticancer agent 5-fluorouracil (5-FU) primarily within tumor cells themselves. This preferential activation within cancerous tissue is made possible by the enzyme thymidine phosphorylase, which is found at significantly higher concentrations in many tumors compared to normal healthy tissue. This tumor-selective mechanism allows for more targeted anti-cancer activity with potentially fewer systemic side effects compared to traditional intravenous 5-FU chemotherapy. As a fluoropyrimidine antimetabolite, the activated drug works by interfering with DNA and RNA synthesis in rapidly dividing cancer cells, ultimately leading to cell death. Capnat is widely prescribed by oncologists around the world for the treatment of metastatic breast cancer (particularly in patients whose tumors have not responded adequately to anthracycline and taxane-based therapies), metastatic and locally advanced colon cancer, and as adjuvant therapy for stage III (Dukes' C) colorectal cancer following complete surgical resection. One of the most significant advantages of choosing to buy capecitabine in the form of Capnat is the convenience of oral administration — patients can undergo effective cancer treatment at home rather than requiring frequent, time-consuming hospital visits for intravenous chemotherapy infusions, significantly improving quality of life during treatment.

Dosage and direction
The dosage of Capnat is carefully and individually calculated based on the patient's body surface area (BSA), which takes into account both height and weight. The standard recommended dose of capecitabine is 1,250 mg/m² taken orally twice daily (once in the morning and once in the evening, approximately 12 hours apart) for 14 consecutive days, followed by a 7-day rest period during which no medication is taken. This 21-day cycle constitutes one complete treatment course and is typically repeated for a total of 6 to 8 cycles, depending on the type and stage of cancer being treated and the patient's response to this fluoropyrimidine therapy. This Xeloda generic should be taken within 30 minutes after completing a meal (breakfast and dinner) with a full glass of water — taking capecitabine with food is important because it improves absorption and reduces the incidence of certain gastrointestinal side effects. Tablets should always be swallowed whole and never crushed, cut, dissolved, or chewed, as the intact tablet coating is designed to protect the drug during its passage through the stomach. Your oncologist will determine the precise number of tablets per dose, the number of treatment cycles, and whether any dosage reductions are necessary based on the severity and type of side effects you experience. Dose modifications are common and important — they help maintain the balance between cancer treatment effectiveness and manageable toxicity. Always follow the prescribed chemotherapy regimen carefully and precisely when you buy capecitabine for breast cancer or colon cancer treatment, and never adjust doses on your own.

Precautions
Before starting Capnat, your oncologist will order comprehensive baseline laboratory tests to evaluate liver function (AST, ALT, bilirubin, alkaline phosphatase), kidney function (creatinine clearance), and complete blood counts with differential. Regular and frequent monitoring of these parameters is absolutely essential throughout treatment, as this antimetabolite chemotherapy can cause clinically significant myelosuppression (bone marrow suppression), leading to potentially dangerous decreases in white blood cell counts (neutropenia, increasing infection risk), red blood cell counts (anemia), or platelet counts (thrombocytopenia, increasing bleeding risk). Of critical importance, patients must be screened for dihydropyrimidine dehydrogenase (DPD) deficiency before treatment initiation. DPD is the enzyme primarily responsible for metabolizing fluoropyrimidines, and patients with partial or complete DPD deficiency are at extremely high risk for severe, prolonged, and potentially life-threatening or fatal toxicity from capecitabine — including severe mucositis, diarrhea, neutropenia, and neurotoxicity. Inform your doctor thoroughly if you have any history of heart disease or coronary artery disease (as cardiotoxicity has been reported with fluoropyrimidine therapy), liver or kidney problems (dosage adjustment is required for renal impairment), diabetes, or previous radiation therapy (which may increase the risk of radiation recall reactions). Adequate hydration is important throughout treatment to support kidney function and manage diarrhea. Both male and female patients of reproductive age must use highly effective contraception during active cancer treatment and for at least 6 months afterward, as this antimetabolite can cause serious harm to an unborn child. Avoid prolonged sun exposure and use broad-spectrum sunscreen, as capecitabine is known to increase photosensitivity of the skin.

Contraindications
Capnat is contraindicated in patients with known hypersensitivity to capecitabine, 5-fluorouracil, or any other component of the formulation, as well as in patients with a documented history of severe or unexpected reactions to fluoropyrimidine therapy. This Xeloda generic must absolutely not be used in patients with known complete dihydropyrimidine dehydrogenase (DPD) deficiency, as administration in this population can result in fatal toxicity within days of starting treatment. It is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min), as reduced drug clearance leads to significantly increased exposure and unacceptable toxicity. Pregnant and breastfeeding women must not use this fluoropyrimidine antimetabolite under any circumstances due to the confirmed risk of teratogenicity, embryotoxicity, and serious harm to the infant. Concurrent use with sorivudine or its chemically related analogues (such as brivudine) is strictly and absolutely contraindicated, as these antiviral agents powerfully inhibit DPD, resulting in dramatically increased fluoropyrimidine levels that can cause fatal bone marrow suppression — a minimum 4-week washout period is required after discontinuation of brivudine before capecitabine can be safely initiated.

Possible side effects
Common side effects of this Xeloda generic include hand-foot syndrome (palmar-plantar erythrodysesthesia), which is one of the hallmark toxicities of capecitabine and manifests as progressive redness, tenderness, swelling, tingling, pain, and eventual peeling or blistering of the skin on the palms of the hands and soles of the feet. This condition can range from mild cosmetic changes to severely debilitating symptoms that interfere with daily activities. Other frequently reported effects of this chemotherapy include diarrhea (which can become severe and require medical intervention), nausea, vomiting, loss of appetite (anorexia), fatigue and asthenia, painful mouth sores (stomatitis and mucositis), and abdominal pain or cramping. This antimetabolite cancer treatment may also cause clinically significant bone marrow suppression, resulting in increased susceptibility to serious infections (due to neutropenia), symptomatic anemia requiring transfusion, and easy bruising or prolonged bleeding (due to thrombocytopenia). Less common but notable side effects include skin rash and dermatitis, hyperbilirubinemia (elevated bilirubin levels), potentially dangerous dehydration (especially when combined with severe diarrhea), taste changes (dysgeusia), and eye irritation or excessive tearing. Serious but rare adverse effects include cardiotoxicity (manifesting as chest pain, angina, irregular heartbeat, or even myocardial infarction), severe and life-threatening diarrhea leading to rapid dehydration and electrolyte imbalance, and hepatotoxicity. Contact your oncologist immediately — without waiting for your next scheduled appointment — if you experience severe diarrhea (more than 4 stools per day above your normal pattern), fever above 100.5°F (38°C), significant hand-foot symptoms that impair function, signs of bleeding or infection, chest pain, or any other alarming symptoms during cancer treatment.

Drug interaction
Capnat has several critically important drug interactions that must be carefully identified and managed before and during treatment. This fluoropyrimidine must never be used concurrently with sorivudine or brivudine, as this combination inhibits DPD and causes fatal fluoropyrimidine toxicity — there are documented fatalities from this interaction. Warfarin and other coumarin-based anticoagulants may have their effects significantly and unpredictably enhanced when taken with capecitabine, dramatically increasing the risk of dangerous or fatal bleeding events — close and frequent INR monitoring (at least weekly initially) is absolutely essential, with prompt warfarin dose adjustments as needed. Phenytoin (Dilantin) blood levels may increase substantially during concurrent use with this antimetabolite, potentially causing phenytoin toxicity (ataxia, nystagmus, confusion); regular therapeutic drug monitoring and dose adjustment are required. Leucovorin (folinic acid) enhances both the efficacy and toxicity of 5-FU and therefore capecitabine — while this combination is sometimes used intentionally in certain treatment protocols, it requires very careful dose management and enhanced toxicity monitoring. Antacids containing aluminum and magnesium hydroxide may slightly increase capecitabine absorption, which is generally not clinically significant but should be noted. Allopurinol may reduce the effectiveness of fluoropyrimidine chemotherapy and should generally be avoided. Always inform your oncologist about every medication, supplement, vitamin, and herbal product you are taking when you buy Capnat online for breast cancer or colon cancer treatment.

Missed dose
If a dose of Capnat is missed, do not take the missed dose at a later time. Simply skip it entirely and take the next dose at its regularly scheduled time with food. Do not take a double dose to compensate for the missed one, as doubling your dose of this potent chemotherapy can significantly and dangerously increase the risk of serious side effects including severe myelosuppression, mucositis, and diarrhea. Contact your oncologist promptly if you miss multiple doses or are unsure about how to proceed, as adjustments to your chemotherapy schedule or dosing may be necessary to maintain the effectiveness of your cancer treatment while ensuring your safety.

Overdose
An overdose of Capnat (capecitabine) may result in severe and potentially life-threatening manifestations of its known side effects, including intractable nausea, severe vomiting, profuse diarrhea leading to rapid dehydration, profound bone marrow suppression with pancytopenia, gastrointestinal bleeding, and severe mucositis. In cases of suspected overdose, discontinue the medication immediately and seek emergency medical attention without delay. Treatment is entirely supportive and may include aggressive intravenous fluid resuscitation for dehydration management, correction of electrolyte imbalances, administration of growth factors for bone marrow recovery, blood transfusions if needed, and intensive monitoring of all organ systems. There is no specific antidote for capecitabine overdose, making prevention through careful dose calculation and adherence to prescribed regimens the most important safety measure.

Storage
Store Capnat at controlled room temperature between 20–25°C (68–77°F), with brief excursions permitted between 15–30°C (59–86°F). Protect from moisture, excessive heat, and direct light. Keep this chemotherapy medication in its original packaging and securely out of reach of children, pets, and individuals for whom it is not prescribed — accidental ingestion of even a single dose by someone not under oncological supervision can be extremely dangerous. This antimetabolite should be handled with appropriate care — avoid direct skin contact with broken, crushed, or damaged tablets, and wash hands thoroughly after handling intact tablets. Caregivers and family members should wear disposable gloves when handling this medication. Do not use after the expiration date printed on the packaging or blister strip. Dispose of unused or expired cancer treatment medication strictly according to local hazardous pharmaceutical waste guidelines — do not dispose of cytotoxic medications in regular household trash or flush them down the toilet. Consult your pharmacist or oncology clinic for proper cytotoxic drug disposal procedures.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.